Financials Ildong Holdings Co., Ltd.

Equities

A000230

KR7000230003

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-05-02 pm EDT 5-day change 1st Jan Change
8,790 KRW -0.11% Intraday chart for Ildong Holdings Co., Ltd. -0.23% -16.44%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 141,469 119,395 156,395 167,123 227,536 118,793
Enterprise Value (EV) 1 170,700 246,923 269,921 290,383 409,242 361,257
P/E ratio -36.2 x -5.35 x -8.15 x -2.36 x -2.11 x -1.99 x
Yield 1.52% 0.9% 0.72% 0.68% 0.5% 0.95%
Capitalization / Revenue 3.01 x 0.41 x 0.26 x 0.28 x 0.34 x 0.19 x
EV / Revenue 3.63 x 0.84 x 0.45 x 0.49 x 0.61 x 0.57 x
EV / EBITDA 64.1 x -50.5 x 9.73 x -6.97 x -6.96 x -8.68 x
EV / FCF 109 x -5.18 x 24.8 x 3.08 x -2.98 x -8.78 x
FCF Yield 0.92% -19.3% 4.04% 32.5% -33.6% -11.4%
Price to Book 0.82 x 0.87 x 1.27 x 3.13 x 19.3 x 3.05 x
Nbr of stocks (in thousands) 11,296 11,294 11,292 11,292 11,292 11,292
Reference price 2 12,524 10,571 13,850 14,800 20,150 10,520
Announcement Date 3/14/19 3/12/20 3/18/21 3/17/22 3/16/23 3/14/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 47,050 292,221 596,469 592,375 675,540 638,448
EBITDA 1 2,664 -4,888 27,752 -41,660 -58,832 -41,608
EBIT 1 -267 -25,871 -10,493 -81,732 -98,263 -79,553
Operating Margin -0.57% -8.85% -1.76% -13.8% -14.55% -12.46%
Earnings before Tax (EBT) 1 -2,944 -47,273 -28,408 -176,529 -172,950 -132,077
Net income 1 -3,719 -22,459 -19,185 -70,891 -102,353 -59,587
Net margin -7.91% -7.69% -3.22% -11.97% -15.15% -9.33%
EPS 2 -345.7 -1,975 -1,699 -6,278 -9,555 -5,277
Free Cash Flow 1 1,566 -47,672 10,896 94,273 -137,411 -41,144
FCF margin 3.33% -16.31% 1.83% 15.91% -20.34% -6.44%
FCF Conversion (EBITDA) 58.76% - 39.26% - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 190.5 95.24 100.0 100.0 100.0 100.0
Announcement Date 3/14/19 3/12/20 3/18/21 3/17/22 3/16/23 3/14/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 29,230 127,528 113,526 123,260 181,706 242,464
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 10.97 x -26.09 x 4.091 x -2.959 x -3.089 x -5.827 x
Free Cash Flow 1 1,566 -47,672 10,896 94,273 -137,411 -41,144
ROE (net income / shareholders' equity) -2.26% -16.4% -9.65% -50.2% -93.7% -58%
ROA (Net income/ Total Assets) -0.06% -3.02% -0.82% -5.9% -6.89% -5.72%
Assets 1 6,018,391 743,883 2,354,033 1,201,658 1,486,043 1,042,383
Book Value Per Share 2 15,221 12,183 10,867 4,723 1,046 3,450
Cash Flow per Share 2 3,128 9,247 11,115 15,466 8,767 6,304
Capex 1 3,141 9,364 18,142 17,153 12,698 13,487
Capex / Sales 6.68% 3.2% 3.04% 2.9% 1.88% 2.11%
Announcement Date 3/14/19 3/12/20 3/18/21 3/17/22 3/16/23 3/14/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A000230 Stock
  4. Financials Ildong Holdings Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW